Nemolizumab
id:
nemolizumab-179-17369869
title:
Nemolizumab
text:
Nemolizumab, sold under the brand name Nemluvio, is a medication for the treatment of prurigo nodularis. It is a monoclonal antibody that blocks the interleukin-31 receptor A. Nemolizumab was invented by Chugai, who sold an exclusive license for the drug's development and worldwide marketing to Galderma in 2016. Nemolizumab was approved for medical use in the United States in August 2024.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Nemolizumab
date created:
2017-04-19T14:06:37Z
date modified:
2024-09-05T05:46:13Z
main entity:
{"identifier":"Q30314619","url":"https://www.wikidata.org/entity/Q30314619"}
image:
fields total:
13
integrity:
15